Subscribe

Category: Expert Perspectives in Vitiligo

Tristan Hasbargen, PA-C: Setting Expectations for a Long-Term Approach to Repigmentation

Tristan Hasbargen, PA-C, of Dermatology Associates of Tallahassee, discusses the treatment of Vitiligo, with a focus on helping patients develop realistic expectations for the repigmentation

PLAY
Chantel Hillestad, RN, MSN, DCNP, FNP-C: Treating Patients with Vitiligo on the Hands

Chantel Hillestad discusses the unique challenges involved in treating Vitiligo affecting the hands, an area that is often more resistant to repigmentation due to lower

PLAY
Chantel Hillestad, RN, MSN, DCNP, FNP-C: Restoring Pigmentation in Patients with Vitiligo

Chantel Hillestad, RN, MSN, DCNP, FNP-C, shares clinical experience using ruxolitinib to restore pigmentation in vitiligo patients across all age groups. Topics Covered: Ruxolitinib for

PLAY
Jennifer Silva, APRN-DNP: Safety Considerations for Treating Patients with Vitiligo

Jennifer Silva discusses important safety considerations when treating patients with Vitiligo using JAK inhibitors, emphasizing the need for clear patient counseling regarding black box warnings

PLAY
Jennifer Silva, APRN-DNP: Providing Adequate Treatment for Patients with Vitiligo

Jennifer Silva, APRN-DNP, outlines treatment options for patients with vitiligo who have not responded well to traditional therapies. Topics Covered: Challenges in vitiligo treatment Strategies

PLAY
Gina Mangin, MPAS, PA-C: Coaching Pearls for Patients with Vitiligo

Gina Mangin discusses patient-centered strategies for managing Vitiligo, emphasizing the importance of encouragement, education, and ongoing motivation throughout the treatment journey. Her presentation highlights how

PLAY
Gina Mangin, MPAS, PA-C: Using Light Box Therapy for Patients with Vitiligo

Gina Mangin, MPAS, PA-C, discusses the role of light box therapy in vitiligo management, with a focus on setting clear expectations around treatment timelines and

PLAY
Shanna Miranti, MPAS, PA-C: Prescribing Ruxolitinib for Patients with Vitiligo

Shanna Miranti, MPAS, PA-C, discusses prescribing considerations for topical ruxolitinib in patients with vitiligo, emphasizing the importance of prior treatment attempts with topical corticosteroids and

PLAY
Shanna Miranti, MPAS, PA-C: Assessing Treatment Efficacy in Patients with Vitiligo
Shanna Miranti, MPAS, PA-C, discusses the similar efficacy seen in patients treated with ruxolitinib at diagnosis versus those who had disease for years.
PLAY
Shanna Miranti, MPAS, PA-C: Managing the Psychosocial Impact of Vitiligo
Shanna Miranti, MPAS, PA-C, discusses the bimodal distribution of vitiligo in male and female individuals and the necessary counseling for those who are managing their
PLAY
Andrea Nguyen, PA-C, MS: Determining Treatment Goals and Expectations for Patients with Vitiligo
Andrea Nguyen discusses how she counsels patients with vitiligo and emphasizes the importance in communicating with patients about consistent application and dosing during a treatment
PLAY
Raj Chovatiya, MD, PhD: Utilizing Ruxolitinib Cream for Patients with Vitiligo
Dr. Chovatiya discusses how to effectively treat patients with nonsegmental vitiligo using topical ruxolitinib cream and the importance in a slow and steady treatment regimen.
PLAY
Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo
Dr. Elbuluk discusses results of the clinical trials for ruxolitinib cream in patients with vitiligo and how this treatment is being incorporated into the dermatologist’s
PLAY
John Harris, MD, PhD: Effective Treatment for Patients with Vitiligo
John Harris, MD, PhD, Chair of Dermatology at UMass Chan Medical School, discusses the impact topical ruxolitinib cream has had on patients with vitiligo. He
PLAY
Seemal Desai, MD, FAAD: Updated Advancements in Vitiligo Treatment
Seemal Desai, MD, a board-certified dermatologist in private and academic practice in Dallas, Texas, discusses the positive impact a recent topical approval has shown for
PLAY
Susan Taylor, MD: The Impact of Vitiligo on Patients of Color​
Susan Taylor, MD, Professor of Dermatology at The University of Pennsylvania in Philadelphia, Pennsylvania, reviews the burden of vitiligo on patients of color and reviews
PLAY
Nada Elbuluk, MD: Current and Future Treatment Options for Patients with Vitiligo
Nada Elbuluk, MD, a board certified dermatologist at the University of Southern California in Los Angeles, California, discusses the importance of offering a variety of
PLAY
John Harris, MD, PhD: The Evolution of Treatments for Vitiligo
John Harris, MD, PhD, Chair of Dermatology at Umass Chan Medical School, reviews the history of treatments for vitiligo, current treatments for vitiligo and their
PLAY
Pearl Grimes, MD: The Psychological Impact of Vitiligo and Advancements in Treatment
Pearl Grimes, MD, Director of of Vitiligo and Pigmentation Institute of Southern California and Clinical Professor of Dermatology at UCLA discusses exciting advancements in therapy
PLAY

More JCAD.TV:

JCAD

Journal of Clinical and Aesthetic Dermatology

Facebook-f X-twitter Instagram Linkedin Youtube Spotify

©2026 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.